Analyst Ratings for Mirum Pharmaceuticals (MIRM)
MIRM Rating Summary
MIRM Price Target Summary
- Highest: $185.00 (H.C. Wainwright)
- Lowest: $110.00 (Raymond James)
- Average: $139.79
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$139.79 (+17.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/2/2026 | Citi | Yigal Nochomovitz | New Coverage | Buy (N/A) |
145.00 (N/A) |
96.33 (118.86) |
23.39% | Details |
| 5/20/2026 | JPMorgan » Updated 7/2/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
125.00 (115.00) |
95.49 (118.86) |
24.47% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
